Trexquant Investment LP - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$1,283,000
+37.2%
52,639
-19.8%
0.09%
+56.9%
Q4 2018$935,000
-49.7%
65,609
-46.3%
0.06%
-58.6%
Q3 2018$1,859,000
+543.3%
122,287
+591.0%
0.14%
+600.0%
Q1 2018$289,000
-80.2%
17,697
-84.5%
0.02%
-87.5%
Q4 2017$1,457,000
+301.4%
113,813
+175.4%
0.16%
+180.7%
Q4 2016$363,000
-61.1%
41,332
-79.8%
0.06%
-28.8%
Q3 2015$933,000
+60.9%
204,612
+154.2%
0.08%
+23.1%
Q2 2015$580,000
-8.7%
80,493
-6.6%
0.06%0.0%
Q1 2015$635,00086,2120.06%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders